Blood-Based Tests for Colorectal Cancer Screening: Do They Threaten the Survival of the FIT Test?

被引:36
作者
Bresalier, Robert S. [1 ]
Kopetz, Scott [2 ]
Brenner, Dean E. [3 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Gastroenterol Hepatol & Nutr, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept GI Med Oncol, Houston, TX 77030 USA
[3] Univ Michigan, Dept Med Oncol, Ann Arbor, MI 48109 USA
关键词
Colon cancer; Screening; Blood-based markers; Fecal occult blood testing; ENDOTHELIAL GROWTH-FACTOR; TUMOR-ASSOCIATED ANTIGEN; SEPTIN; 9; DNA; COLON-CANCER; GLYCOPROTEIN MICROARRAYS; BINDING PROTEIN-3; POTENTIAL MARKER; PLASMA-INSULIN; FACTOR-I; SERUM;
D O I
10.1007/s10620-015-3575-2
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Colorectal cancer is the second leading cause of cancer death in industrialized nations, accounting for 10 % of the total cancer burden with an individual lifetime risk of similar to 6 % in the USA (Siegel et al. in CA Cancer J Clin 62:9-29, 2014, American Cancer Society in Colorectal cancer facts and figures 2011-2013. American Cancer Society, Atlanta, 2011, Siegel et al. in CA Cancer J Clin 61:212-236, 2011). Although numerous screening methods have been incorporated into guidelines for colorectal cancer screening, no guideline includes a noninvasive blood-based test as a recommended option.
引用
收藏
页码:664 / 671
页数:8
相关论文
共 66 条
[61]   Loss of insulin-like growth factor-II imprinting and the presence of screen-detected colorectal adenomas in women [J].
Woodson, K ;
Flood, A ;
Green, L ;
Tangrea, JA ;
Hanson, J ;
Cash, B ;
Schatzkin, A ;
Schoenfeld, P .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (05) :407-410
[62]   Enhanced Discrimination of Malignant from Benign Pancreatic Disease by Measuring the CA 19-9 Antigen on Specific Protein Carriers [J].
Yue, Tingting ;
Maupin, Kevin A. ;
Fallon, Brian ;
Li, Lin ;
Partyka, Katie ;
Anderson, Michelle A. ;
Brenner, Dean E. ;
Kaul, Karen ;
Zeh, Herbert ;
Moser, A. James ;
Simeone, Diane M. ;
Feng, Ziding ;
Brand, Randall E. ;
Haab, Brian B. .
PLOS ONE, 2011, 6 (12)
[63]   Serologic Autoantibodies as Diagnostic Cancer Biomarkers-A Review [J].
Zaenker, Pauline ;
Ziman, Melanie R. .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2013, 22 (12) :2161-2181
[64]   Microfluidics and cancer: are we there yet? [J].
Zhang, Zhuo ;
Nagrath, Sunitha .
BIOMEDICAL MICRODEVICES, 2013, 15 (04) :595-609
[65]   Glycoprotein microarrays with multi-lectin detection: Unique lectin binding patterns as a tool for classifying normal, chronic pancreatitis and pancreatic cancer sera [J].
Zhao, Jia ;
Patwa, Tasneem H. ;
Qiu, Weilian ;
Shedden, Kerby ;
Hinderer, Robert ;
Misek, David E. ;
Anderson, Michelle A. ;
Simeone, Diane M. ;
Lubman, David M. .
JOURNAL OF PROTEOME RESEARCH, 2007, 6 (05) :1864-1874
[66]   N-linked glycosylation profiling of pancreatic cancer serum using capillary liquid phase separation coupled with mass spectrometric analysis [J].
Zhao, Jia ;
Qiu, Weilian ;
Simeone, Diane M. ;
Lubman, David M. .
JOURNAL OF PROTEOME RESEARCH, 2007, 6 (03) :1126-1138